metformin and proton pump inhibitors may lower B12
Product quality, delivery method, dosage, cycle length, and medical history all affect safety
Substantial human trial data for full-length TB-4 (corneal-healing Phase 2/3 as RGN-259, plus cardiac and wound-repair programs), with clean Phase 1 safety. Cosmetic dosing is extrapolated from these programs
BPC-157 also preserves neuromuscular function by stabilizing acetylcholine receptors and nerve terminals at the neuromuscular junction (NMJ), effectively reversing paralysis induced by neuromuscular blockers such as succinylcholine and lidocaine [24, 43, 44]
Although the role of ADE in long COVID is less well-characterized, limited evidence suggests that ADE-associated antibodies, such as anti-nucleocapsid antibodies, may contribute to disease pathogenesis primarily through immune activation (mechanism illustrated in Figure 1B) [85,86,87]